跳至主要内容
临床试验/NCT07032376
NCT07032376已完成不适用

Guideline to Implementation: A Rapid Clinical Care Pathway to Care for Patients Affected by Chronic Constipation- Phase 2

University of Michigan2 个研究点 分布在 1 个国家目标入组 49 人开始时间: 2025年8月20日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
49
试验地点
2
主要终点
Percentage of encounters in which anorectal physiology testing is ordered or performed at the baseline routine-care gastroenterology office appointment

研究概览

简要总结

This research is studying how the availability of a Food and Drug Administration (FDA)-cleared point-of-care, bedside device bedside device called Rectal Expulsion Device (RED) can be used to evaluate constipation in the participants' routine office visit with the participants' care provider. In this research, participants will be asked to complete a survey prior to the gastroenterology office consultation. Health-related information will be collected for this research study. There are no additional study visits for this research study.

详细描述

This registration is (Implementation Phase) for the registered study "Guideline to Implementation: A Rapid Clinical Care Pathway to Care for Patients Affected by Chronic Constipation" (Observational Phase) NCT06352827.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Participants:
  • •- Participant has Chronic constipation as a main symptom

排除标准

  • •Participants:
  • •Participant has taken narcotic pain medication in the past 30 days
  • •Participant has been scheduled for a test called an anorectal manometry in the past 12 months
  • •Participant has been scheduled to see a pelvic floor physical therapist in the past 12 months
  • •Participant is pregnant

研究组 & 干预措施

Chronic constipation

Experimental

Participants will complete surveys and may or may not have the Rectal Expulsion Device (FDA 510k approved) used during clinic visit.

干预措施: Survey (Behavioral)

Chronic constipation

Experimental

Participants will complete surveys and may or may not have the Rectal Expulsion Device (FDA 510k approved) used during clinic visit.

干预措施: Rectal Expulsion Device use (Behavioral)

结局指标

主要结局

Percentage of encounters in which anorectal physiology testing is ordered or performed at the baseline routine-care gastroenterology office appointment

时间窗: Day 1 (Baseline = initial appointment after consent)]

Fidelity to ordering pelvic floor diagnostics

Percentage of encounters in which pelvic floor physical therapy is ordered at the baseline routine-care gastroenterology office appointment

时间窗: Day 1 (Baseline = initial appointment after consent)]

Fidelity to ordering pelvic floor treatment

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Eric Shah

Associate Professor of Internal Medicine

University of Michigan

研究点 (2)

Loading locations...

相似试验